Shukhrat Abdurakhmanov, Chief Minister of Andijan region of Uzbekistan and Dr.Ranvir Singh — Chairman of Mumbai based Taj Pharmaceuticals

Taj Pharmaceuticals will open a Pharmaceuticals Manufacturing facility in the region Andijan - Uzbekistan

• Published on February 9, 2019
• Edit article
• View stats

Shantanu Kumar Singh

Status is online

Shantanu Kumar Singh

Director at TAJ PHARMA GROUP

3 articles

• 25
• Unlike1
• Comment0
• 1

Source: Executive Shantanu Singh | Taj Pharmaceuticals Group | Taj Pharma India

Chief Minister of Andijan region of Uzbekistan meets directors of Taj Pharmaceuticals

Shukhrat Abdurakhmanov, Chief Minister of Andijan region of Uzbekistan, today met Dr.Ranvir Singh — Chairman of Mumbai based Taj Pharmaceuticals. Taj Pharmaceuticals will open a Pharmaceuticals Manufacturing facility in the region Andijan.

Khokimiyat of the Andijan region of the Republic of Uzbekistan (hereinafter - the Uzbek side), and Taj Pharmaceuticals Group, the Republic of India intending to establish closer economic ties between the two countries by strengthening cooperation in the pharmaceutical and chemical industries, concentrating on cooperation in the joint implementation of a project establishing pharmaceutical company in Indian-Uzbek Free Pharmaceutical Zone in Andijan region of the Republic of Uzbekistan, recognizing the importance of the growth of industrial sectors in both countries and the importance of mutual cooperation in trade, pharmaceutical and chemical industries, the creation of joint ventures

Uzbekistan eyes to emerge as India’s gateway to Central Asia

Uzbekistan President Shavkat Mirziyoyev will attend Vibrant Gujarat international investment summit as a key guest of the Prime Minister Narendra Modi on January 18–20 , with an eye to upgrade ties to a new level opening a new chapter in India’s Central Asia outreach.

This visit comes days after the maiden India-Central Asia and Afghan meet in Samarkand, Uzbekistan last Sunday.

This is the second visit of Mirziyoyev to India during the last four months. State visit of Uzbekistan’s President in October 2018 opened a new chapter in Uzbek-India relations, including wider trade and investment cooperation.

Participation of Uzbekistan in Vibrant Gujarat summit includes government and business level meetings, trade show exhibition, country seminar and the first meeting of Uzbekistan-India Business Council. As Uzbekistan is opening up as an investment destination,Indian businessmen look at the country as a hub for further expansion within the resource rich region. Economic liberalization, rapid political reforms and encouragement of FDI make Uzbekistan an inviting destination for business and investment . Indian companies are exploring investment opportunities in the pharmaceutical , textile , education, IT, tourism and other sectors in Uzbekistan. To attract investments in the pharmaceutical sector, an Uzbek Indian Free Pharmaceutical Zone is being developed in the Andijan region. This project was among 17 agreements that were signed during the Uzbek president’s State visit to India. A direct flight between Tashkent and Mumbai, launched last year, also facilitate s business between western India and Central Asia. Tourists flow from India to Uzbekistan increased 30% for the last year.

High level delegation of Uzbekistan at Gujarat summit includes heads of Investment Committee, Trade Committee, Chamber of Commerce, Ministry of Foreign Affairs as well as more than 60 business owners, CEOs of biggest national and private companies of Uzbekistan.

Country pavilion of Uzbekistan at Gujarat Trade Show will expose large spectrum of industries including automobile, metallurgy, pharmaceutical, construction, IT, banking, textile and leather, machinery, food processing, tourism, education and others.

The country seminar of Uzbekistan will take place on the second day of Vibrant Gujarat forum on January 18, 2019. Special focus will be made on Uzbek Indian Free Pharmaceutical Zone in Andijan region of Uzbekistan . Andijan and Gujarat are developing mutual cooperation within a partnership memorandum.

Uzbekistan-India Business council will also held its first meeting during the Gujarat summit. The launch of Business Council was announced during the State v isit of Uzbekistan president to India in October 2018. T he council facilitate s initiatives pertaining to the promotion of trade and investment, business alliances and possibilities of direct collaboration between companies from both the countries in sectors such as agriculture and agro-processing, health-care, education, textile and apparel, chemicals and pharmaceutical, leather, auto and engineering, energy, gems and jewelry, tourism, amongst others .

The Government of Uzbekistan is working with foreign investment banks and other international financial institutions to realise the vast economic and social reforms. President Mirziyoyev recently signed an ‘Innovative Development Strategy for 2019–2021 and the Road Map for its implementation’. The strategy aims at ‘the development of human capital as the main factor enhancing Uzbekistan’s competitiveness and innovation.’ By implementing this, Uzbekistan plans to join the ranks of 50 advanced countries in the Global Innovation Index by 2030.Dynamics of current development of Uzbekistan is highly acknowledged internationally. The Doing Business 2018 report ranks Uzbekistan 74th among 190 countries. The country has moved 13 places up in and was also included in the ‘Top 10 improvers’, based on reforms undertaken.

Uzbekistan provides most favored nation (MFN) status to 45 countries, including India.Friendly investment environment is based on a reliable legal frame and wide range of guarantees and benefits for investors, including tax incentives, providing land and buildings on attractive terms.

In Uzbekistan, 18 free economic zones (FEZ) have been established with a 30-year operational life and the possibility of a subsequent extension. Seven of them have a pharmaceutical focus.

Company Overview of Taj Pharmaceuticals Limited

Taj Pharmaceuticals Limited manufactures and distributes medicines. The company’s products include prescription solutions, lifesaving drugs, anti-cancer drugs, veterinary products, consumer brands, and CNS drugs. It focuses on medicines of anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases. Taj Pharmaceuticals Limited was founded in 2004 and is headquartered in Mumbai, India.